Angels Santé

MB Therapeutics is a pharmaceutical company that specializes in patient-centric solutions for the development and production of tailored medicines. It operates a system that enables the creation of customized medications, including the combination of multiple active ingredients into a single unit, and offers evaluation services. The company's focus is on enhancing treatment precision and improving patient adherence through the customization of medication dosage and forms.

Sirius NeoSight is a biotechnology and pharmaceutical company focused on the early detection and treatment of subclinical neo-cancers. The company has developed innovative healthcare technology software that measures the fluidity of membranes specifically within the field of oncology. This patented technology is designed to enhance the detection and purification of Circulating Tumor Cells, contributing to advancements in personalized medicine. By addressing these critical aspects of cancer treatment, Sirius NeoSight aims to improve outcomes for patients through early intervention and tailored therapeutic approaches.

Hephaistos Pharma is a biotechnology company focused on advancing oncology treatments through innovative immunotherapy solutions. The firm develops a platform that utilizes active and non-specific immuno-stimulants to enhance the effectiveness of existing antibodies by transforming cold tumors into hot targets, which can significantly improve patient outcomes. This approach aims to address unmet medical needs in cancer treatment, enabling patients to tackle previously incurable cancers. Hephaistos Pharma is dedicated to elevating immunotherapy efficiency by stimulating immune responses, thereby offering new hope in the fight against cancer. Interested parties can access more information through an online inquiry form available on the company's website.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Abcely is a biotechnology company focused on developing innovative medical and pharmaceutical technologies aimed at treating mucosal cancers. The firm is engaged in creating a novel anti-cancer medication that leverages a new concept of immunotherapy. By utilizing active therapeutic molecules, Abcely identifies compounds of biological origin that may serve as potential active ingredients. The company's approach is designed to enhance the effectiveness of cancer treatment, providing healthcare professionals with advanced tools to combat this disease in clinical settings.

Odimma is a biotech company specializing in precision medicine aimed at developing personalized cancer immunotherapy solutions. The company has created an innovative immunotherapy drug that harnesses a unique platform, integrating three specific immune components designed to work together with the patient's immune system. When administered, this approach aims to induce and enhance immune responses, providing patients with the potential to eliminate tumors while minimizing adverse side effects. Through its focus on personalized treatment strategies, Odimma seeks to improve outcomes for cancer patients by tailoring therapies to individual needs.

Ensweet is a telemedicine platform focused on providing telerehabilitation services to patients. The platform is designed to facilitate accessible rehabilitation care by offering essential equipment, including heart rate sensors and physical activity devices. This enables patients to exercise safely and effectively in various environments, ensuring that rehabilitation is within reach for all individuals regardless of their circumstances.

Healshape is a biotech startup dedicated to developing natural breast reconstruction solutions for women. The company specializes in regenerative medicine, focusing on creating innovative alternatives for breast regeneration through advanced 3D bioprinting technology. Healshape's primary product is a bioprosthesis designed for breast reconstruction, which aims to empower women by helping them regain self-confidence and achieve long-lasting, aesthetically pleasing results following surgery.

Vaxxel is a biotechnology company focused on developing innovative live-attenuated vaccines targeting critical respiratory diseases, specifically bronchiolitis and pneumonia caused by pneumoviruses. The company specializes in creating novel vaccine candidates aimed at treating infections associated with human metapneumovirus and the human respiratory virus. By leveraging its proprietary platform, Vaxxel aims to provide effective solutions for healthcare providers to combat these significant health challenges.

Mapatho operates an online medical directory and search platform that helps patients locate free medical and paramedical experts. The platform is organized by chronic pathologies, addressing the challenge of post-diagnosis medical wandering by connecting patients with relevant health professionals. By fostering a collaborative ecosystem, Mapatho enables individuals with chronic diseases to find specialized care and support, enhancing their ability to navigate the healthcare system effectively.

Gaoma Therapeutics is a biotechnology company dedicated to developing therapeutic molecules aimed at addressing unmet medical needs in neurological and inflammatory diseases. With a particular focus on epilepsy and cognitive disorders, the company is advancing its initial medicine candidate, GAO-3-02, which is a novel proprietary active component. Gaoma Therapeutics also has plans to explore the potential applications of its compounds in additional therapeutic areas, utilizing a portfolio of innovative lipid derivatives as drug candidates to enhance treatment options for healthcare organizations and their patients.

OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

Omini is a French company, established in 2019 and based in Saint Mandé, that specializes in the development of portable and multipurpose bio-sensing devices for blood testing. The company’s biosensor platform allows for the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to tailor therapies and prevent acute crises in patients with chronic conditions. By employing advanced multiplex electrochemical biosensor technology, Omini's devices offer accurate and affordable solutions for identifying, analyzing, and monitoring various target biomarkers. This innovation supports decentralized testing and at-home monitoring, ultimately aiming to alleviate the burden on healthcare systems and improve patient outcomes. Omini primarily serves general practitioners, enhancing their ability to manage patient care effectively.

Braintale is a Paris-based company founded in 2018 that develops and distributes diagnostic and prognostic tools specifically designed for brain-injured patients. Its platform focuses on analyzing MRI reports to assist healthcare professionals in effectively diagnosing patients who are in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. With over 15 years of clinical development backing its products, Braintale aims to meet the expectations of both healthcare professionals and patients by providing accessible and effective tools for prognosis and diagnosis in critical care settings.

GoSense is a company focused on creating innovative solutions to enhance the perception of visually impaired individuals. It develops sensory enhancement technologies that include a sound-based GPS and travel assistant, which helps users navigate their environment through spatialized sound. Additionally, GoSense offers smart sensory devices designed to detect obstacles and prevent injuries, alongside outside-the-ear headphones that allow users to stay aware of their surroundings. These products aim to empower visually impaired persons to travel safely and independently.

SeaBeLife Biotech SAS is a biotechnology company based in Roscoff, France, established in 2019. The company focuses on developing innovative drug candidates aimed at treating acute pathologies, particularly acute liver and renal failure. SeaBeLife's products are derived from a family of patented molecules designed to block regulated necrosis, a type of regulated cell death. By targeting two synergistic pathways involved in various acute and chronic diseases, SeaBeLife aims to establish a new standard of care for patients with significant unmet medical needs. Through its research and development efforts, the company seeks to enhance patient outcomes and reduce complications associated with serious health conditions.

Hillo is a company based in Palaiseau, France, founded in 2016, specializing in the development of an artificial intelligence platform aimed at transforming the lives of diabetic patients. The company creates tools for continuous blood glucose monitoring that adapt to individual patient needs. Their software synchronizes with insulin delivery devices, logs treatment history, assesses meal intake, and learns from behavioral and physiological responses. This enables real-time predictions of blood glucose levels and provides personalized treatment suggestions, ultimately enhancing diabetes management for patients. Hillo's services are geared toward the medical industry, focusing on improving health outcomes for those living with diabetes.

Primaa is a MedTech company that specializes in developing an AI-based platform for the automated and accurate diagnosis of cancer. The company's innovative software utilizes image analysis and deep learning techniques to improve the detection of key cancer biomarkers. By digitizing histological slides and compiling images into a comprehensive database, Primaa's technology allows medical professionals to efficiently identify tissue damage and conduct a growing number of diagnoses with a high degree of reliability. This approach not only enhances diagnostic accuracy but also supports personalized treatment plans for patients.

Wefight Inc. specializes in developing technology for the healthcare sector, focusing on improving personalized patient care. The company's flagship application, Vik-Sein, is designed to assist breast cancer patients by addressing their questions, providing reminders for treatment adherence, and offering smart tracking features to match patients with relevant clinical trials. Founded in 2017 and based in Montpellier, France, Wefight aims to enhance patient support outside of traditional clinical settings. The platform allows for the collection of real-world data, enabling patients to manage their health at home while facilitating more efficient communication between patients and care teams. Additionally, the use of an AI-powered virtual companion helps patients navigate their healthcare journeys and allows doctors to gain insights into their patients' daily experiences with illness.

SentinHealth is a life science company that specializes in developing integrated care solutions aimed at tracking and preventing the progression of chronic illnesses. The company focuses on telemonitoring technology, which includes an implant connected to the cloud that provides daily health status updates and predictive information. This innovative approach is particularly beneficial for patients with serious chronic conditions, as it allows for early detection of health issues, such as acute decompensated heart failure (ADHF), before they require emergency care. By addressing the critical need for continuous monitoring in patients, SentinHealth aims to improve health outcomes and reduce the demand for acute medical interventions.

OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

C4Diagnostics specializes in the development and commercialization of in vitro diagnostic (IVD) kits utilizing its proprietary technology. The company focuses on creating medical devices and equipment that enhance the speed and sensitivity of diagnostic tests. One of its primary offerings includes solutions for urinary tract infection screening, which reliably detects, counts, and concentrates culturable microorganisms relevant to clinical microbiology. This capability allows hospitals and laboratories to conduct culture-based IVD tests with improved accuracy and efficiency, contributing to better patient outcomes in diagnostic processes.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, specializes in developing non-invasive ultrasonic medical devices aimed at treating heart valve diseases. The company's innovative technology focuses on real-time image guidance to address conditions such as calcified aortic stenosis, minimizing thermal injury and allowing for efficient treatment by clinicians. With a commitment to advancing medical care, Cardiawave has raised over €14 million since its inception to support product development and preclinical studies, paving the way for expected clinical trials to begin. The experienced management team, recognized for its excellence, continues to drive the company's mission to improve patient outcomes in cardiovascular health.

PREMEDIT SAS is a French company that specializes in developing application software branded as Running Care, aimed at helping runners predict, prevent, and manage injuries and pain. Utilizing artificial intelligence, the software monitors runners' health and serves as a class I medical device for diagnosing and rehabilitating running-related injuries, compliant with relevant medical regulations. In addition to its core functionalities, Running Care offers integration with other running applications, affiliate marketing for sports and healthcare products, and provides a platform for content aimed at non-healthcare professionals. The company, founded in 2016 and headquartered in Loos, France, also focuses on sports medicine data analysis and promoting awareness of health issues related to sports.

Hillo is a company based in Palaiseau, France, founded in 2016, specializing in the development of an artificial intelligence platform aimed at transforming the lives of diabetic patients. The company creates tools for continuous blood glucose monitoring that adapt to individual patient needs. Their software synchronizes with insulin delivery devices, logs treatment history, assesses meal intake, and learns from behavioral and physiological responses. This enables real-time predictions of blood glucose levels and provides personalized treatment suggestions, ultimately enhancing diabetes management for patients. Hillo's services are geared toward the medical industry, focusing on improving health outcomes for those living with diabetes.

Auxivia, established in 2015 and headquartered in Paris, France, specializes in designing and developing smart glasses connected to an online platform. These glasses, indistinguishable from regular ones, track water intake and alert users to prevent dehydration. The company's innovative solution aims to enhance caregiving quality for elderly individuals, particularly those with declining autonomy, by enabling caregivers to monitor and manage their water intake effectively.

Cypheme is a company that has developed an artificial intelligence application focused on detecting counterfeit products. The application utilizes machine learning and pattern recognition techniques to analyze product packaging through a smartphone camera. By examining the micro-structure of items, Cypheme's technology enables users to determine the authenticity of products, helping to combat the growing issue of counterfeit goods in the market. This innovative approach allows for quick and efficient verification, empowering consumers and businesses alike to ensure they are purchasing genuine items.

Cardiawave, established in late 2014 through a collaboration between the Langevin Institute and the Georges Pompidou European Hospital, specializes in developing non-invasive ultrasonic medical devices aimed at treating heart valve diseases. The company's innovative technology focuses on real-time image guidance to address conditions such as calcified aortic stenosis, minimizing thermal injury and allowing for efficient treatment by clinicians. With a commitment to advancing medical care, Cardiawave has raised over €14 million since its inception to support product development and preclinical studies, paving the way for expected clinical trials to begin. The experienced management team, recognized for its excellence, continues to drive the company's mission to improve patient outcomes in cardiovascular health.

BibeliB is a brand of smart and trendy travel accessories. They created the first smart suit case. This suitcase bag is equipped with e an integrated traceability and insurance system. Thanks to our My BibeliB Paris app your suitcase cover is now connected to geolocate your suitcase and activate it more easily.

Medicapp Connect S.A.S., incorporated in 2011 and based in Paris, France, specializes in designing and developing healthcare software solutions. The company focuses on applications that assist healthcare professionals in managing patient data effectively. Its flagship product, Medicapp EHR, is a mobile application that allows users to create, fill, classify, and communicate patient records, as well as manage health documents and notes. The software aims to simplify recordkeeping for healthcare providers, enhancing the overall efficiency of healthcare data management.

Ensweet is a telemedicine platform focused on providing telerehabilitation services to patients. The platform is designed to facilitate accessible rehabilitation care by offering essential equipment, including heart rate sensors and physical activity devices. This enables patients to exercise safely and effectively in various environments, ensuring that rehabilitation is within reach for all individuals regardless of their circumstances.